The France Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The France Journal.

Press releases published on April 13, 2026

Apr. 13, 2026

Tribuna.com Présente 15 Fonctionnalités qui Redéfinissent les Possibilités d'une Application Football

Indeterminate EIN Presswire

Apr. 13, 2026

PulseForge Achieves Sub-10 µm Silicon Breakthrough in Ultra-Thin Wafer Processing with Photonic Debonding

Indeterminate EIN Presswire

Apr. 13, 2026

Hannover House sets ambitious production slate for launch at Cannes Festival

Indeterminate EIN Presswire

Apr. 13, 2026

Vol de marchandises : peu d’inquiétudes de la part des gestionnaires de flotte malgré les risques

Indeterminate EIN Presswire

Apr. 13, 2026

New SOCIETIES Edition Spotlights AI, Wellness and Design in the Shift Toward Intentional Luxury

Indeterminate EIN Presswire

Apr. 13, 2026

ABL Diagnostics Announces Two New Scientific Publications, Reinforcing its Expertise in HIV Sequencing-based Genotyping

Indeterminate EIN Presswire

Apr. 13, 2026

ADIFF Presents Transcultural Dialogues Film Series April 24–26, 2026 at Teachers College, Columbia University

Indeterminate EIN Presswire

Apr. 13, 2026

Soil Management Market Is Going to Boom – Growth Opportunities Through 2033 | Bayer Crop Science AG, Novozymes

Indeterminate EIN Presswire

Apr. 13, 2026

Applications Open for DNDA26 Awards: Celebrating Humanity-Centered Design for Societal Impact and Global Well-Being

Indeterminate EIN Presswire

Apr. 13, 2026

Doyield repositionne le débat OTA à l’ère de l’IA dans un podcast de 10 minutes hotels qui bouscule les idées reçues

Indeterminate EIN Presswire

Apr. 13, 2026

Technip Energies launches its 2026 Employee Share Offering

Indeterminate GlobeNewswire

Apr. 13, 2026

Technip Energies lance son offre d'actionnariat salarié 2026

Indeterminate GlobeNewswire

Apr. 13, 2026

Ministers and Members of Parliament at Paris Blockchain Week 2026: A Historic Signal for the Institutionalization of Crypto-Assets

Indeterminate GlobeNewswire

Apr. 13, 2026

Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer

Indeterminate GlobeNewswire

Apr. 13, 2026

Transgene annonce la fin de la randomisation des patients de la partie Phase 2 de l’essai clinique évaluant TG4050 dans le traitement adjuvant des cancers de la tête et du cou

Indeterminate GlobeNewswire

Apr. 13, 2026

Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria

Indeterminate GlobeNewswire

Apr. 13, 2026

Communiqué de presse : Dupixent de Sanofi et Regeneron approuvé dans l'UE comme premier médicament ciblé contre l'urticaire chronique spontanée chez les jeunes enfants

Indeterminate GlobeNewswire